New online platform helps dementia caregivers cope with grief
NCT ID NCT06225986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an online platform called the Living Memory Home for Dementia Care Pairs (LMH-4-DCP). It helps people with dementia and their family caregivers share and record meaningful memories together. The goal was to see if using the platform could reduce feelings of grief in caregivers and improve the quality of their relationship. Seventy-four care pairs participated, using the platform three times a week for two weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
online reminiscence platform (Living Memory Home for Dementia Care Pairs)
What this could lead to
If it works, this could provide a simple, low-cost way to help dementia caregivers feel less grief and strengthen their bond with their loved one.
What could go wrong
This was a small, early feasibility study with only 74 participants, so results may not apply to everyone. The platform requires internet access and English skills, which limits who can use it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10021, United States